A5006919751- Aortic aneurysm repair treatments
- Peripheral Artery Disease Management
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Renal and Vascular Pathologies
- Global Health Care Issues
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Global Maternal and Child Health
- Diagnosis and Treatment of Venous Diseases
- Coronary Interventions and Diagnostics
- Healthcare Systems and Reforms
- Acute Ischemic Stroke Management
- MRI in cancer diagnosis
- Ultrasound in Clinical Applications
- Retirement, Disability, and Employment
- Cerebral Venous Sinus Thrombosis
- Vascular Procedures and Complications
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Vascular anomalies and interventions
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
Beth Israel Deaconess Medical Center
2023-2025
Deaconess Hospital
2023-2025
Harvard University
2023-2024
United States Food and Drug Administration
2024
NYU Langone Health
2024
Deaconess Hospital
2024
Abstract Aims Prior trials have demonstrated that intravascular imaging (IVI)-guided percutaneous coronary intervention (PCI) results in less frequent target lesion revascularization and major adverse cardiovascular events (MACEs) compared with standard angiographic guidance. The uptake associated outcomes of IVI-guided PCI contemporary clinical practice the USA remain unclear. Accordingly, temporal trends comparative relative to guidance alone were examined a broad, unselected population...
BACKGROUND: Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic aneurysmal intervention, there is a paucity of literature aimed at understanding long-term disparities. The present study aims to characterize outcomes, perioperative health care use endovascular aneurysm repair. METHODS: We conducted retrospective cohort from 2011 2019 with outcome assessment through 2020. Using 100% sample national Medicare data, we identified...
Meningioma resection is associated with the risk of venous thromboembolism (VTE).To determine incidence and factors for VTE following meningioma outcomes based on type timing anticoagulation.From 2011 to 2019, 901 consecutive patients underwent resection. We retrospectively evaluated postoperative bleeding. For VTE, we determined treatment strategy rate complications bleeding.Pharmacologic prophylaxis was administered 665 (73.8%) patients. The cumulative total 8.7% (95% CI: 6.9%-10.6%),...
Importance Inferior vena cava filters (IVCFs) are commonly used to prevent pulmonary embolism in selected clinical scenarios, despite limited evidence support their use. Current recommendations from professional societies and the US Food Drug Administration endorse timely IVCF retrieval when clinically feasible. treatment patterns outcomes remain poorly described. Objectives To evaluate temporal trends practice insertion among older patients report incidence of periprocedural long-term...
Peripheral arterial disease poses significant public health challenges, particularly among minority and the socioeconomically disadvantaged patients. This study scrutinized trends in femoropopliteal revascularization procedures outcomes amidst clinical practice changes catalyzed by paclitaxel-coated device controversy, COVID-19 pandemic, BEST-CLI trial results. Leveraging Medicare/Medicaid administrative claims from 2016 to 2023, linked with Distressed Communities Index Rural-Urban Continuum...
The first percutaneous microaxial left ventricular assist device's (Impella; Abiomed) use has significantly increased since its Food and Drug Administration (FDA) clearance for short-term mechanical circulatory support in severe failure 2008.1 More recently, the FDA expanded indications Impella device patients with acute myocardial infarction cardiogenic shock (AMICS). While utilization of annually,2,3 disparities growth patterns dissemination United States among different demographic...
Recent trial data support both surgical-first and endovascular-first revascularization approaches for chronic limb-threatening ischemia (CLTI), but variations outcomes associated with each strategy among capable hospitals are lacking. Medicare beneficiaries CLTI treated at offering endovascular surgical treatments between 10/1/2015 to 12/31/2021 were analyzed. Cumulative incidence of major amputation 1 year calculated across quintiles treatment use. Gray's p-value was generated account...